Gene therapy may free gaucher patients from lifelong infusions
NCT ID NCT07223944
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This Phase 3 trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. The goal is to see if a single dose can keep blood counts stable so patients can stop their regular enzyme replacement or substrate reduction therapy. The study will enroll 45 people who have been on stable treatment for at least 2 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FLT201 gene therapy
- What this could lead to
- If it works, this could allow people with Gaucher disease type 1 to stop their regular enzyme or substrate therapy and maintain stable blood counts with a single treatment.
- What could go wrong
- This is still an early Phase 3 trial with only 45 participants. Gene therapy carries risks like immune reactions or the treatment not lasting. Patients must stop their current therapy, which could cause a relapse if FLT201 fails.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GAUCHER DISEASE TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
NOT_YET_RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
NOT_YET_RECRUITINGCincinnati, Ohio, 45229, United States
-
Clinica Universitaria Reina Fabiola
RECRUITINGCórdoba, X5004ASL, Argentina
-
Columbia University
NOT_YET_RECRUITINGNew York, New York, 10032, United States
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Emory Healthcare
RECRUITINGAtlanta, Georgia, 30322, United States
-
Gazi University Medical Faculty
NOT_YET_RECRUITINGAnkara, Yenimahalle, 06560, Turkey (Türkiye)
-
Hackensack University Medical Center
NOT_YET_RECRUITINGHackensack, New Jersey, 07601, United States
-
Hospital Italiano de Buenos Aires
RECRUITINGBuenos Aires, C1199ABB, Argentina
-
Hospital Militar Central
RECRUITINGBuenos Aires, C1426BOR, Argentina
-
Hospital Quironsalud de Zaragoza
NOT_YET_RECRUITINGZaragoza, 50012, Spain
-
Hospital Universitario Vall d'Hebron
NOT_YET_RECRUITINGBarcelona, Barcelona, 08035, Spain
-
Hospital de Clinicas de Porto Alegre
RECRUITINGPorto Alegre, 90035-903, Brazil
-
Kaiser Permanente - CA
RECRUITINGLos Angeles, California, 90027, United States
-
King Faisal Specialist Hospital and Research Center
NOT_YET_RECRUITINGRiyadh, 12713, Saudi Arabia
-
Lady Davis Institute for Medical Research Jewish General Hospital
RECRUITINGMontreal, Quebec, T2E 7Z4, Canada
-
Lysosomal Rare Disorders Research and Treatment Center
RECRUITINGFairfax, Virginia, 22030-6066, United States
-
MAGIC Clinic Ltd
RECRUITINGCalgary, Alberta, T2E 7H7, Canada
Contact Email: •••••@•••••
-
Melbourne Health - Royal Melbourne Hospital
NOT_YET_RECRUITINGMelbourne N., Victoria, 3051, Australia
-
NYU Langone Health
RECRUITINGNew York, New York, 10017, United States
-
Queen Elizabeth Hospital Birmingham
NOT_YET_RECRUITINGBirmingham, Birmingham, B15 2GW, United Kingdom
-
Rabin Medical Center, Beilinson Hospital
RECRUITINGPetah Tikva, Israel
-
Royal Free Hospital
RECRUITINGLondon, London, NW3 2QG, United Kingdom
-
Salford Royal Hospital
NOT_YET_RECRUITINGSalford, Greater Manchester, M6 8HD, United Kingdom
-
Shaare Zedek Medical Center
RECRUITINGJerusalem, Israel
-
UCLA Health
RECRUITINGLos Angeles, California, 90095, United States
-
UPMC Children's Hospital of Pittsburgh
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
University of California, San Francisco (UCSF)
RECRUITINGSan Francisco, California, 94609, United States
-
University of Colorado Anschutz
RECRUITINGAurora, Colorado, 80045, United States
-
University of Iowa Health Care
NOT_YET_RECRUITINGIowa City, Iowa, 52242, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55454, United States
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill replace infusions for gaucher brain symptoms?
- Can we predict Parkinson's decades early? new study recruits 600 participants
- Cough medicine repurposed: ambroxol registry launches for rare brain diseases
- One-Time gene therapy could change gaucher treatment forever
- Gene therapy trial aims to fix enzyme defect in gaucher disease
- Gene therapy for gaucher disease: 5-year safety check begins